{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:07:28Z","timestamp":1790381248381,"version":"4.1.0"},"reference-count":52,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Vitiligo is a complex disease wherein derangements in multiple pathways determine the loss of functional melanocytes. Since its pathogenesis is not yet completely understood, vitiligo lacks a definitive safe and efficacious treatment. At present, different therapies are available; however, each modality has its baggage of disadvantages and side effects. Recently we have described several metabolic abnormalities in cells from pigmented skin of vitiligo patients, including alterations of glucose metabolism. Therefore, we conducted a study to evaluate the effect of Pioglitazone (PGZ), a Peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3) agonist, on cells from pigmented vitiligo skin. We treated vitiligo melanocytes and fibroblasts with low doses of PGZ and evaluated the effects on mitochondrial alterations, previously reported by our and other groups. Treatment with PGZ significantly increased mRNA and protein levels of several anaerobic glycolytic enzymes, without increasing glucose consumption. The PGZ administration fully restored the metabolic network, replacing mitochondrial membrane potential and mitochondrial DNA (mtDNA) copy number. These effects, together with a significant increase in ATP content and a decrease in reactive oxygen species (ROS) production, provide strong evidence of an overall improvement of mitochondria bioenergetics in vitiligo cells. Moreover, the expression of HMGB1, Hsp70, defined as a part of DAMPs, and PD-L1 were significantly reduced. In addition, PGZ likely reverts premature senescence phenotype. In summary, the results outline a novel mode of action of Pioglitazone, which may turn out to be relevant to the development of effective new vitiligo therapeutic strategies.<\/jats:p>","DOI":"10.3390\/cells11223583","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T04:14:01Z","timestamp":1668399241000},"page":"3583","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPAR\u03b3 Agonist"],"prefix":"10.3390","volume":"11","author":[{"given":"Federica","family":"Papaccio","sequence":"first","affiliation":[{"name":"Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-5500","authenticated-orcid":false,"given":"Barbara","family":"Bellei","sequence":"additional","affiliation":[{"name":"Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ottaviani","sequence":"additional","affiliation":[{"name":"Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"D\u2019Arino","sequence":"additional","affiliation":[{"name":"Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3046-3922","authenticated-orcid":false,"given":"Mauro","family":"Truglio","sequence":"additional","affiliation":[{"name":"Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Caputo","sequence":"additional","affiliation":[{"name":"Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3926-4172","authenticated-orcid":false,"given":"Giovanni","family":"Cigliana","sequence":"additional","affiliation":[{"name":"Clinical Pathology Unit, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Sciuto","sequence":"additional","affiliation":[{"name":"Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Migliano","sequence":"additional","affiliation":[{"name":"Plastic and Regenerative Surgery, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pacifico","sequence":"additional","affiliation":[{"name":"Phototherapy Unit, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Iacovelli","sequence":"additional","affiliation":[{"name":"Phototherapy Unit, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Picardo","sequence":"additional","affiliation":[{"name":"Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: A Review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pcmr.12949","article-title":"An update on Vitiligo pathogenesis","volume":"34","author":"Seneschal","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/pcmr.12878","article-title":"The enigma and challenges of vitiligo pathophysiology and treatment","volume":"33","author":"Jordan","year":"2020","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bellei, B., Pitisci, A., Ottaviani, M., Ludovici, M., Cota, C., Luzi, F., Dell\u2019Anna, M.L., and Picardo, M. (2013). Vitiligo: A possible model of degenerative diseases. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059782"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1038\/s41598-017-13961-5","article-title":"Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin","volume":"7","author":"Ottaviani","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","article-title":"Vitiligo Skin: Exploring the Dermal Compartment","volume":"138","author":"Kovacs","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"eabn9299","DOI":"10.1126\/sciadv.abn9299","article-title":"Altered epidermal proliferation, differentiation, and lipid composition: Novel key elements in the vitiligo puzzle","volume":"8","author":"Kovacs","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/exd.13868","article-title":"Involvement of non-melanocytic skin cells in vitiligo","volume":"28","author":"Bastonini","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"D\u2019Arino, A., Picardo, M., Truglio, M., Pacifico, A., and Iacovelli, P. (2021). Metabolic Comorbidities in Vitiligo: A Brief Review and Report of New Data from a Single-Center Experience. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168820"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hassan, F.U., Nadeem, A., Li, Z., Javed, M., Liu, Q., Azhar, J., Rehman, M.S., Cui, K., and Rehman, S.U. (2021). Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212463"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: The good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20080195","article-title":"PPARgamma and its ligands: Therapeutic implications in cardiovascular disease","volume":"116","author":"Villacorta","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/157489012799362359","article-title":"Selective peroxisome proliferator-activated receptor-\u03b3 modulation to reduce cardiovascular risk in patients with insulin resistance","volume":"7","author":"Yew","year":"2012","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2008.11.141","article-title":"TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis","volume":"379","author":"Fujisawa","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications--A review","volume":"13","year":"2014","journal-title":"Nutr. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biopha.2016.11.105","article-title":"Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis","volume":"85","author":"Ahmed","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","article-title":"AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control","volume":"31","author":"Hall","year":"2020","journal-title":"Cell Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41419-021-03592-0","article-title":"A protective role for autophagy in vitiligo","volume":"12","author":"Bastonini","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jid.2020.01.033","article-title":"Vitiligo: Targeted Therapies Add Color to Disease Pathophysiology","volume":"140","author":"Ezzedine","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1155\/2016\/3401570","article-title":"Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes","volume":"2016","author":"Qiao","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-016-0309-5","article-title":"PPARs modulate cardiac metabolism and mitochondrial function in diabetes","volume":"24","author":"Lee","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/34681","article-title":"MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes","volume":"391","author":"Hemesath","year":"1998","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1101\/gad.14.3.301","article-title":"c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi","volume":"14","author":"Wu","year":"2000","journal-title":"Genes Dev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/excr.2000.4803","article-title":"Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9","volume":"255","author":"Xu","year":"2000","journal-title":"Exp. Cell Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/pcmr.12298","article-title":"Mitochondrial dynamics regulate melanogenesis through proteasomal degradation of MITF via ROS-ERK activation","volume":"27","author":"Kim","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/pcmr.12208","article-title":"Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress","volume":"27","author":"Mosenson","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/0019-5154.185704","article-title":"Heat Shock Protein-70 Expression in Vitiligo and its Relation to the Disease Activity","volume":"61","author":"Doss","year":"2016","journal-title":"Indian J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3389\/fimmu.2018.02707","article-title":"Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis","volume":"9","author":"Raam","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3389\/fimmu.2019.02298","article-title":"The Diverse Function of PD-1\/PD-L Pathway Beyond Cancer","volume":"10","author":"Qin","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/exd.13069","article-title":"Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo","volume":"26","author":"Speeckaert","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s42255-018-0008-5","article-title":"Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis","volume":"1","author":"Zhao","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.R082933","article-title":"Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization","volume":"59","author":"Glatz","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.det.2016.11.014","article-title":"Vitiligo Pathogenesis and Emerging Treatments","volume":"35","author":"Rashighi","year":"2017","journal-title":"Dermatol. Clin."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0749.2006.00333.x","article-title":"A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Picardo","year":"2006","journal-title":"Pigment Cell Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.36290\/vnl.2020.020","article-title":"Pioglitazone","volume":"66","year":"2020","journal-title":"Vnitr. Lek."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12647","article-title":"The role of PPAR\u03b3-mediated signalling in skin biology and pathology: New targets and opportunities for clinical dermatology","volume":"24","author":"Ramot","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Silva-Abreu, M., Espinoza, L.C., Rodr\u00edguez-Lagunas, M.J., F\u00e1brega, M.J., Espina, M., Garc\u00eda, M.L., and Calpena, A.C. (2017). Human Skin Permeation Studies with PPAR\u03b3 Agonist to Improve Its Permeability and Efficacy in Inflammatory Processes. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122548"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.17420111","article-title":"AMP-activated protein kinase: An energy sensor that regulates all aspects of cell function","volume":"25","author":"Hardie","year":"2011","journal-title":"Genes Dev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physiol.00050.2013","article-title":"AMPK: Regulating energy balance at the cellular and whole body levels","volume":"29","author":"Hardie","year":"2014","journal-title":"Physiology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1159\/000443121","article-title":"Pioglitazone, a Peroxisome Proliferator-Activ ated Receptor x03B3; Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5\/6 Nephrectomized Rat Model","volume":"38","author":"Sun","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"658362","DOI":"10.3389\/fphar.2021.658362","article-title":"Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-\u03b3\/PGC-1\u03b1 Signaling Pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: Master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abb.2014.07.019","article-title":"The roles of microphthalmia-associated transcription factor and pigmentation in melanoma","volume":"563","author":"Hsiao","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: Danger from within","volume":"25","author":"Richmond","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"579022","DOI":"10.3389\/fimmu.2020.579022","article-title":"Targeting the PD-1\/PD-L1 Axis in Human Vitiligo","volume":"11","author":"Willemsen","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.abb.2008.05.015","article-title":"Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability","volume":"477","author":"Baranowski","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1210\/jcem.87.5.8450","article-title":"Adipose Tissue IL-6 Content Correlates with Resistance to Insulin Activation of Glucose Uptake Both in vivo and in vitro","volume":"87","author":"Bastard","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/22\/3583\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:17:04Z","timestamp":1760145424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/22\/3583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":52,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["cells11223583"],"URL":"https:\/\/doi.org\/10.3390\/cells11223583","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]}}}